INTENSIFICATION OF CHRONIC MYELOID-LEUKEM IA THERAPY IN RELATION TO THE PROGNOSTIC FACTORS

Authors
Citation
Nd. Khoroshko, INTENSIFICATION OF CHRONIC MYELOID-LEUKEM IA THERAPY IN RELATION TO THE PROGNOSTIC FACTORS, Terapevticeskij arhiv, 66(7), 1994, pp. 30-35
Citations number
6
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00403660
Volume
66
Issue
7
Year of publication
1994
Pages
30 - 35
Database
ISI
SICI code
0040-3660(1994)66:7<30:IOCMIT>2.0.ZU;2-O
Abstract
A multifactorial computer analysis of current modalities in relevant t reatment performed for 208 patients with chronic myeloid leukemia (CML ) has revealed a close relationship between the set of unfavourable fa ctors upon the diagnosis, choice of treatment and the patients' surviv al. For groups of patients with a standard CML risk it is preferable t o use monotherapy. More intensive treatment (polychemotherapy) is indi cated in the disease progression. The patients at moderate and high CM L risk are recommended to be treated intensively (polychemotherapy, po lychemotherapy + leukocytapheresis, splenectomy) from the start, that is upon CML diagnosis. The above approach promotes longer survival of CML patients.